ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Telmisartan+HCTZ, Hypertension

This study has been completed.
Study NCT00659607.   Last updated on November 18, 2008.   Information provided by Boehringer Ingelheim Pharmaceuticals

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Telmisartan+HCTZ, Hypertension
Official Title  PMS Study of MicardisPlus Tablet
Brief Summary

This PMS study aims to review the followings by investigating the actual practice of MicardisPlus Tablet on the market:

  1. Unexpected adverse drug reactions (especially, serious adverse events (SAEs))
  2. Frequency of incidence and its change in adverse events (AEs)
  3. Factors on the safety profile of the study drug
  4. Factors on the efficacy profile of the study drug
Detailed Description
Study Phase Phase IV
Study Type  Observational
Study Design 
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Hypertension
Intervention 
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Completed
Enrollment  7000
Start Date 
Completion Date February 2009
Eligibility Criteria 

Inclusion Criteria:

patients diagnosed as essential hypertension

Exclusion Criteria:

n/a

Gender Both
Ages
Accepts Healthy Volunteers No
Contacts ††
Location Countries  Korea, Republic of
Administrative Information Fields
NCT ID  NCT00659607
Organization ID 502.475
Secondary IDs ††
Study Sponsor  Boehringer Ingelheim Pharmaceuticals
Collaborators ††
Investigators 
Study Chair:     Boehringer Ingelheim Study Coordinator     B.I. Korea Ltd.    
Information Provided By Boehringer Ingelheim Pharmaceuticals
Verification Date November 2008
First Received Date  April 10, 2008
Last Updated Date November 18, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers